Director
Stoke Therapeutics, Inc.
Susovan Mohapatra is currently a Director in the DMPK Department at Stoke Therapeutics. His group is responsible for the development and implementation of bioanalytical and DMPK strategies to support development of oligonucleotide therapeutics targeting CNS diseases. Prior to joining Stoke, Susovan was an Associate Director at Wave Life Sciences in the Bioanalytical and Biomarker team where he supported preclinical and clinical development of stereopure oligonucleotides targeting neurodegenerative diseases. Susovan received his Ph.D. in Pharmacology and Toxicology from Virginia Commonwealth University and continued his training in Bioanalytical chemistry at Massachusetts Institute of Technology as a postdoctoral fellow in the Bioengineering Department. He has over 10 years of experience in supporting preclinical and clinical development of nucleic acid therapeutics and has 11 publications in peer-reviewed journals.